Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the detailed record of transactions filed by Sato Vicki l, Board Member. Officer active across 4 companies, notably Vir Biotechnology, Inc.. Aggregated, 73 reports have been published. Breakdown: 0 buy · 59 sells. Total volume traded: €11m. History available since 19 May 2021. The latest transaction was filed on 1 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sato Vicki l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1666 títulos@ 18,29 US$2.3% de su flujoCommon StockSEC:0001714899-24-000104:0
25 de 73 declaraciones
About Sato Vicki l
SATO VICKI L is Board Member and has filed 73 disclosures in total. In the 73 sampled disclosures, all recorded transactions are sales, for a total of EUR 11021952, between 2021-05-20 and 2026-05-04, mainly related to Vir Biotechnology, Inc. She is also a Director at Vir Biotechnology, Inc., Denali Therapeutics Inc., and Allogene Therapeutics, Inc.